Rheumatoid Arthritis Diagnosis Tests

Global Market Trajectory & Analytics

MCP14459

EXECUTIVE ENGAGEMENTS

POOL

6194
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

991
Interactions with Platform & by Email

PARTICIPANTS

186
Unique # Participated

VALIDATIONS

42
Responses Validated*

COMPANIES

65
Responses Validated*
* Login for a full stack data experience

DATE

AUG 2021

TABLES

204

PAGES

393

EDITION

8

PRICE

USD 4950

CODE

MCP14459


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

S M N T

%

VALIDATED RESEARCH *

S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T

* S = Strong; M = Moderate; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
  

HIGHLIGHTS & REPORT INDEX

Global Rheumatoid Arthritis Diagnosis Tests Market to Reach $766.7 Million by 2026

Rheumatoid Arthritis (RA), a chronic autoimmune disease, causes inflammation in the joints, muscles, connective tissues, fibrous tissues, and tendons causing pain and swelling. The disease is developed when certain cells of the immune system do not work properly and attach the healthy joints. The disease mostly affects the wrists, hands, and feet. In this condition, the body identifies the body tissues as antigens and produces antibodies against them resulting in inflammation. Major symptoms of the disease include swelling, pain, joint stiffness, joint deformity, fever, weight loss, loss of mobility and function, unsteadiness while walking, and weakness. Different types of rheumatoid arthritis are seronegative, seropositive and juvenile idiopathic arthritis. Women are more prone to the disease compared to men and it is common among the age group 40 to 60. The diagnosis of the disease depends on the symptoms, physical examination, x-ray, scan, and blood test results of a patient.

Though the disease can attack at any age its prevalence generally begins in people between 30 to 60 years of age. Females are more two to three times more prone to RA than men. The US had the lowest rate of RA prevalence in the recent past in comparison to the other eight major markets like Australia, the US, Japan, France Italy, Germany, Spain and the UK. The US had an RA prevalence rate of 67% in comparison with the standard 73% rate in the other eight markets. The UK demonstrated the highest prevalence of RA at 84%. Alterations in the population of the U.S are expected to bring an unprecedented increase in the growth of incidence cases of RA in the U.S. till 2027. Physicians in the U.S. are expected to focus heavily on diagnostic processes for RA. Rheumatoid arthritis is better managed when detected early as the inflammation reduction process can be begun early. The clinical demonstration of RA is swelling and redness of joints, pain, swelling and stiffness. Diagnosing the disease involves a physical examination, an array of imaging tests, blood tests and medical history analysis of patients and patient`s families. The diagnosis of RA can be influenced by the challenge of separating the disease from other autoimmune disorders showing similar symptoms. A combination of diagnostic processes including a thorough symptomatic evaluation of the patient, X-ray analysis, blood tests and scans and physical examinations are recommended for the optimal management of this disease.

Amid the COVID-19 crisis, the global market for Rheumatoid Arthritis Diagnosis Tests estimated at US$579.8 Million in the year 2020, is projected to reach a revised size of US$766.7 Million by 2026, growing at a CAGR of 4.8% over the analysis period. Serology Tests, one of the segments analyzed in the report, is projected to grow at a 5.1% CAGR to reach US$561.3 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Monitoring Ra Treatment Efficiency Tests segment is readjusted to a revised 4% CAGR for the next 7-year period. This segment currently accounts for a 31.6% share of the global Rheumatoid Arthritis Diagnosis Tests market.

The U.S. Market is Estimated at $124.3 Million in 2021, While China is Forecast to Reach $113.5 Million by 2026

The Rheumatoid Arthritis Diagnosis Tests market in the U.S. is estimated at US$124.3 Million in the year 2021. The country currently accounts for a 20.66% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$113.5 Million in the year 2026 trailing a CAGR of 6.1% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR while Rest of European market (as defined in the study) will reach US$120.4 Million by the close of the analysis period.

Global demographic trends spell opportunities for the rheumatoid arthritis (RA) diagnostic tests market. It is acknowledged that prevalence of RA increases with age, and therefore rising aging population widens the demand for diagnosis tests as well as treatments for RA. Over the course of the next two decades, the proportion of 65+ individuals in the total population is expected to double in countries such as the US, UK and Australia. As per the World Health Organization (WHO), total number of people aged 65-years and above is projected to grow from the existing 605 million to nearly 2 billion by the year 2050. While nearly 89 million people in the US are forecast to be 65-years or above by 2050, around 40% of citizens in Japan are projected to belong to the age group by 2060. While the increase in life expectancy represents one of the greatest achievements of the past century, it also poses a significant challenge for healthcare systems. People might live more years but the average number of healthy years is on a decline given the risk of contracting later life conditions such as dementia. About 55% of global healthcare expenditure is likely to be spent on chronic diseases including cardiovascular diseases, cancer and respiratory diseases.

With advancing age, the incidence of various health ailments increases, necessitating the need for laboratory tests for diagnosing the specific diseases such as RA. Impact of autoimmune diseases such as RA on quality of life and associated high cost of treatments are prompting governments and healthcare providers to encourage preventive care, especially with focus on aging population. The growing aging population is therefore offering continuous opportunities for the autoimmune disease diagnostics market, as with advancing age the incidence of various autoimmune conditions such as RA increases, which results in rise in testing volumes translating to higher demand for testing techniques for RA. As RA is mostly common among the old people, and the geriatric population has been increasing recently, the opportunities in the global rheumatoid arthritis diagnosis test market are expected to be on the rise in the future.

SELECT PLAYERS

Abbott Diagnostics; Augurex Life Sciences Corp.; Beckman Coulter, Inc.; Bio Rad Laboratories Inc.; Exagen Inc.; F. Hoffmann-La Roche Ltd.; Genway Biotech, Inc.; Microdrop LLC (imaware); Qiagen NV; Siemens Healthcare GmbH; Svar Life Science AB; Thermo Fisher Scientific Inc.

SEGMENTS

» Test Type (Serology Tests, Monitoring RA Treatment Efficiency Tests) » End-Use (Diagnostic Laboratories, Hospitals, Ambulatory Surgical Centers)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
A Prelude to Rheumatoid Arthritis
Causes and Risk Factors
Symptoms
Rheumatoid Arthritis Diagnostic Tests
Serological Tests
Monitoring RA Treatment Efficiency Tests
Impact of Covid-19 and a Looming Global Recession
Impact of COVID-19 on Rheumatoid Arthritis Diagnostic Tests
Global Market Outlook and Prospects
Global Rheumatoid Arthritis Diagnostic Tests Market Set to Witness Significant Growth
Select RA Diagnostic Tests by Player
The US and Europe Dominate the Global Market, Developing Countries to Witness Fastest Growth
Competition
Recent Market Activity
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence of Rheumatoid Arthritis Propels the Demand for Rheumatoid Arthritis Diagnosis
Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
Growing Aging Population to Drive the Demand for RA Diagnostic Tests
EXHIBIT 11: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Increasing Use of Rapid Diagnosis Tests Platform
Select List of RA Biomarkers used in Clinical Practice
Investigational Biomarkers to Diagnose and Monitor RA
New Biomarker Tests to Drive the Market Growth
More Specific Biomarker Tests
Growing Demand for Multiple Tests
Repercussions of Sub Optimal Accuracy in RA Testing Drive the Need for Multiple Tests
Recent Advancements in Treatment Methods to Boost Market Growth
Uptrend in Healthcare Expenditure Drives Opportunities
EXHIBIT 13: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Increase in Number of Hospitals & Diagnostics Centers Augurs Well for Market in Developing Regions
Increasing Obesity Levels Underpins Market Growth
EXHIBIT: Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
Technological Advancements Widen the Capabilities of RA Arthritis Tests
A Few of the Recent Launches and Advancements
Rapid RA Diagnostic Tests for Obtaining Results in Minutes
imaware™ Introduces At-Home Rheumatoid Arthritis Screening Test
Swedish Biotech Breaks Barrier to Diagnosis with Rheumatoid Arthritis Test
Scipher Medicine® Ties Up with Ambry Genetics® to Bring Precision Medicine Test for Rheumatoid Arthritis to Market
A New Blood Test Could to Predict Rheumatoid Arthritis
A New Blood Test Could to Predict Rheumatoid Arthritis
IPM Launches Innovative Program for Rheumatoid Arthritis
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
World Current & Future Analysis for Serology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Serology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Serology Tests by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Current & Future Analysis for Monitoring RA Treatment Efficiency Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Monitoring RA Treatment Efficiency Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Monitoring RA Treatment Efficiency Tests by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
UNITED STATES
USA Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
USA Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
CANADA
Canada Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Canada Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
JAPAN
Japan Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Japan Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
CHINA
China Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
China Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
EUROPE
Europe Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Europe Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
FRANCE
France Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
France Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
GERMANY
Germany Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Germany Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
ITALY
Italy Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Italy Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
UK Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
SPAIN
Spain Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Spain Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
RUSSIA
Russia Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Russia Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Rest of Europe Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
Asia-Pacific Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Asia-Pacific Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
AUSTRALIA
Australia Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Australia Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
INDIA
India Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
India Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
South Korea Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Rest of Asia-Pacific Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
Latin America Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Latin America Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
ARGENTINA
Argentina Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Argentina Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
BRAZIL
Brazil Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Brazil Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
MEXICO
Mexico Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Mexico Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Rest of Latin America Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
Middle East Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Middle East Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
IRAN
Iran Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Iran Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
ISRAEL
Israel Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Israel Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Saudi Arabia Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
UAE Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Rest of Middle East Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
AFRICA
Africa Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Rheumatoid Arthritis Diagnosis Tests by Test Type - Serology Tests and Monitoring RA Treatment Efficiency Tests Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by Test Type - Percentage Breakdown of Value Revenues for Serology Tests and Monitoring RA Treatment Efficiency Tests for the Years 2012, 2021 & 2027
Africa Current & Future Analysis for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Rheumatoid Arthritis Diagnosis Tests by End-Use - Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Rheumatoid Arthritis Diagnosis Tests by End-Use - Percentage Breakdown of Value Revenues for Diagnostic Laboratories, Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
Total Companies Profiled: 65

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com